Mogy Joel R Investment Counsel’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-36,880
| Closed | -$5.76M | – | 106 |
|
|
2023
Q2 | $5.76M | Buy |
36,880
+481
| +1% | +$75.1K | 0.46% | 38 |
|
|
2023
Q1 | $5.9M | Buy |
36,399
+1,179
| +3% | +$191K | 0.52% | 38 |
|
|
2022
Q4 | $5.63M | Buy |
35,220
+1,013
| +3% | +$162K | 0.56% | 37 |
|
|
2022
Q3 | $4.82M | Sell |
34,207
-939
| -3% | -$132K | 0.5% | 39 |
|
|
2022
Q2 | $5.12M | Buy |
35,146
+330
| +0.9% | +$48.1K | 0.51% | 40 |
|
|
2022
Q1 | $5.65M | Buy |
34,816
+1,145
| +3% | +$186K | 0.45% | 39 |
|
|
2021
Q4 | $6.38M | Buy |
33,671
+2,635
| +8% | +$499K | 0.46% | 41 |
|
|
2021
Q3 | $6.27M | Buy |
31,036
+1,619
| +6% | +$327K | 0.51% | 37 |
|
|
2021
Q2 | $5.93M | Buy |
29,417
+1,580
| +6% | +$319K | 0.5% | 37 |
|
|
2021
Q1 | $4.88M | Buy |
27,837
+2,847
| +11% | +$500K | 0.47% | 39 |
|
|
2020
Q4 | $4.24M | Buy |
24,990
+120
| +0.5% | +$20.4K | 0.42% | 40 |
|
|
2020
Q3 | $4.03M | Buy |
24,870
+500
| +2% | +$81K | 0.43% | 40 |
|
|
2020
Q2 | $3.97M | Buy |
24,370
+2,447
| +11% | +$399K | 0.48% | 39 |
|
|
2020
Q1 | $2.81M | Sell |
21,923
-2,286
| -9% | -$293K | 0.4% | 44 |
|
|
2019
Q4 | $3.38M | Buy |
24,209
+210
| +0.9% | +$29.3K | 0.4% | 44 |
|
|
2019
Q3 | $2.83M | Buy |
23,999
+1,245
| +5% | +$147K | 0.36% | 48 |
|
|
2019
Q2 | $2.94M | Buy |
22,754
+1,595
| +8% | +$206K | 0.38% | 46 |
|
|
2019
Q1 | $2.72M | Buy |
21,159
+2,454
| +13% | +$315K | 0.37% | 46 |
|
|
2018
Q4 | $2.07M | Buy |
18,705
+1,340
| +8% | +$148K | 0.32% | 52 |
|
|
2018
Q3 | $2.36M | Buy |
17,365
+1,270
| +8% | +$173K | 0.32% | 55 |
|
|
2018
Q2 | $1.93M | Buy |
16,095
+940
| +6% | +$113K | 0.29% | 58 |
|
|
2018
Q1 | $1.82M | Buy |
15,155
+1,040
| +7% | +$125K | 0.28% | 60 |
|
|
2017
Q4 | $1.76M | Buy |
14,115
+9,525
| +208% | +$1.19M | 0.28% | 63 |
|
|
2017
Q3 | $616K | Buy |
4,590
+1,720
| +60% | +$231K | 0.1% | 91 |
|
|
2017
Q2 | $361K | Buy |
2,870
+695
| +32% | +$87.4K | 0.06% | 104 |
|
|
2017
Q1 | $259K | Buy |
+2,175
| New | +$259K | 0.04% | 112 |
|